Recent Patents on Cardiovascular Drug Discovery (Discontinued)

When Cells Become a Drug. Endothelial Progenitor Cells for Cardiovascular Therapy: Aims and Reality
pp. 1-10(10)
Authors: Burba, Ilaria; Devanna, Paolo; Pesce, Maurizio

Atrial Fibrillation – Advances in Drug Therapy
pp. 11-19(9)
Authors: Nanda, Sudip; Siddique, Sultan M.; Martinez, Matthew W.; Sharma, Shree G.; Patel, Nainesh C.; Longo, Santo

Bivalirudin: Alternative Anticoagulation During Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia
pp. 20-24(5)
Authors: Grubb, Kendra J.; Salehi, Payam; Chedrawy, Edgar G.

Aldose Reductase Inhibition: Emerging Drug Target for the Treatment of Cardiovascular Complications
pp. 25-32(8)
Authors: Reddy, Aramati B.M.; Ramana, Kota V.

Pharmacological Modulations of Cardiac Ultra-Rapid and Slowly Activating Delayed Rectifier Currents: Potential Antiarrhythmic Approaches
pp. 33-46(14)
Author: Islam, Mohammed A.

Dronedarone – A New Alternative for Management of Atrial Fibrillation
pp. 47-53(7)
Authors: Hundal, Mandeep; Garg, Rajeev K.

Mitochondrially Targeted Antioxidants for the Treatment of Cardiovascular Diseases
pp. 54-65(12)
Authors: Subramanian, Sharath; Kalyanaraman, Balaraman; Migrino, Raymond Q.

Dopexamine After Heart Surgery: An Uncommonly Used, Though Useful Inotropic Agent
pp. 66-68(3)
Authors: Tagarakis, Georgios I.; Stylianakis, Georgios E.; Tsilimingas, Nikolaos B.

New Strategies and Drugs in the Treatment of Hypertension: Monotherapy or Combination?
pp. 69-81(13)
Authors: Destro, Maurizio; Cagnoni, Francesca; D'Ospina, Antonio; Ricci, Alessandra R.; Zaninelli, Augusto; Preti, Paola

Patent Selections
pp. 82-85(4)
Author: Bentham Science Publishers